Teva Pharmaceutical Industries Ltd. — Earnings Release 2007

Oct 17, 2007

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD.

Contact: Liraz Kalif / Kevin Mannix Teva Investor Relations (011) 972-3-926-7281 / (215) 591-8912

FOR IMMEDIATE RELEASE

TEVA TO REPORT THIRD QUARTER 2007 FINANCIAL RESULTS ON OCTOBER 30, 2007

CONFERENCE CALL SCHEDULED FOR 8:30 AM ET

Jerusalem, Israel, October 17, 2007 – Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its third quarter 2007 financial results on Tuesday, October 30, 2007.

Teva will host a conference call and live webcast on that same day, at 08:30AM ET to discuss its third quarter 2007 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva’s web site at www.tevapharm.com prior to the call.

Investors and other interested parties may access a live webcast through Teva’s web site at www.tevapharm.com. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours at the Company’s web site. Alternatively, a replay of the call can be accessed until November 6, 2007 at 11:59 (ET), by calling 1-(201) 612-7415 outside the U.S. or 1-(877) 660-6853 in the U.S. The Pass Code to access the replay is: Account #3055 and Conference ID #258957.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 75% of Teva’s sales are in North America and Europe.

Investor Relations

5 Basel St., P.O.Box 3190 Petach-Tikva 49131, Israel

Tel: 972-3-9267281 Fax: 972-3-9267519 www.tevapharm.com